KalVista meets main goals in late-stage trial for skin condition treatment

(Reuters) – KalVista Pharmaceuticals said on Tuesday its therapy for a type of skin condition met the main goals in a late-stage trial.

(Reporting by Christy Santhosh; Editing by Shilpi Majumdar)